Guizhou Xinbang Pharmaceutical Co., Ltd. (002390.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap6.11B
Enterprise Value5.67B
P/E Ratio43.81
PEG Ratio0.83
Price/Sales Ratio1.01
Price/Book Ratio0.78
Enterprise/Revenue0.91
Enterprise/EBITDA13.61

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.02
Operating Margin0.04
AD

Management Effectiveness

Return On Assets0.01
Return On Equity0.02

Income Statement

Revenue5.61B
Revenue/Share2.87
Gross Profit877.77M
EBITDA464.2M
Net Income120.29M
Diluted EPS0.06

Balance Sheet

Total Cash1.15B
Total Cash/Share0.61
Total Debt618.72M
Total Debt/Equity0.09
Current Ratio3.5
Book Value Per Share3.75

Price History

52-Week Change-17.01
52-Week High4.15
52-Week Low2.65
Moving Average 50 Days3.12
Moving Average 200 Days3.42

Statistics

Average Volume27.35M
Shares Outstanding1.94B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.09
Trailing Annual Dividend Yield3.18
Payout Ratio1.8
Last Split Factor5:2
Last Split DateMay 25, 2015
AD